Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ion Channels | 26 | 2022 | 204 | 4.010 |
Why?
|
| Ion Channel Gating | 20 | 2022 | 176 | 3.120 |
Why?
|
| Protons | 22 | 2022 | 84 | 2.810 |
Why?
|
| Zinc | 10 | 2020 | 39 | 1.010 |
Why?
|
| NADPH Oxidases | 12 | 2020 | 43 | 0.830 |
Why?
|
| Mutation | 9 | 2019 | 330 | 0.700 |
Why?
|
| Point Mutation | 1 | 2018 | 25 | 0.560 |
Why?
|
| Animals | 20 | 2022 | 3270 | 0.530 |
Why?
|
| Eosinophils | 6 | 2006 | 36 | 0.470 |
Why?
|
| Proton Pumps | 3 | 2008 | 12 | 0.460 |
Why?
|
| Membrane Potentials | 9 | 2019 | 168 | 0.450 |
Why?
|
| Hydrogen-Ion Concentration | 10 | 2021 | 125 | 0.410 |
Why?
|
| HEK293 Cells | 6 | 2019 | 59 | 0.380 |
Why?
|
| Phagocytes | 4 | 2008 | 18 | 0.340 |
Why?
|
| Humans | 27 | 2020 | 22932 | 0.300 |
Why?
|
| Membrane Transport Modulators | 1 | 2007 | 2 | 0.260 |
Why?
|
| Mice | 8 | 2020 | 1238 | 0.250 |
Why?
|
| Protein Conformation | 4 | 2019 | 63 | 0.250 |
Why?
|
| COS Cells | 6 | 2015 | 38 | 0.240 |
Why?
|
| Membrane Glycoproteins | 2 | 2002 | 47 | 0.240 |
Why?
|
| Amino Acid Sequence | 4 | 2015 | 142 | 0.230 |
Why?
|
| Molecular Sequence Data | 4 | 2015 | 176 | 0.230 |
Why?
|
| Dinoflagellida | 2 | 2017 | 4 | 0.220 |
Why?
|
| Models, Theoretical | 1 | 2003 | 76 | 0.190 |
Why?
|
| B-Lymphocytes | 2 | 2014 | 50 | 0.190 |
Why?
|
| Histidine | 3 | 2018 | 6 | 0.180 |
Why?
|
| Neutrophils | 3 | 2009 | 89 | 0.180 |
Why?
|
| Snails | 2 | 2018 | 5 | 0.180 |
Why?
|
| Respiratory Burst | 4 | 2009 | 26 | 0.170 |
Why?
|
| Molecular Dynamics Simulation | 3 | 2019 | 9 | 0.170 |
Why?
|
| Binding Sites | 1 | 2020 | 67 | 0.170 |
Why?
|
| Electrophysiology | 6 | 2010 | 95 | 0.160 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2020 | 16 | 0.160 |
Why?
|
| Cell Proliferation | 1 | 2020 | 163 | 0.150 |
Why?
|
| Membrane Proteins | 1 | 2020 | 140 | 0.150 |
Why?
|
| Cadmium | 3 | 2018 | 11 | 0.150 |
Why?
|
| Reactive Oxygen Species | 4 | 2014 | 102 | 0.140 |
Why?
|
| Sequence Homology | 1 | 2018 | 3 | 0.140 |
Why?
|
| Protein Domains | 1 | 2018 | 6 | 0.140 |
Why?
|
| Cricetinae | 1 | 2018 | 33 | 0.140 |
Why?
|
| Rats | 2 | 2018 | 623 | 0.140 |
Why?
|
| Models, Molecular | 4 | 2015 | 74 | 0.130 |
Why?
|
| Vacuoles | 1 | 2017 | 7 | 0.130 |
Why?
|
| Patch-Clamp Techniques | 5 | 2014 | 97 | 0.120 |
Why?
|
| Aspartic Acid | 2 | 2015 | 12 | 0.120 |
Why?
|
| Tryptophan | 1 | 2015 | 10 | 0.120 |
Why?
|
| Protein Binding | 3 | 2015 | 112 | 0.110 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2014 | 14 | 0.110 |
Why?
|
| Hematologic Neoplasms | 1 | 2014 | 17 | 0.110 |
Why?
|
| Structural Homology, Protein | 1 | 2013 | 3 | 0.100 |
Why?
|
| Enzyme Activation | 4 | 2010 | 109 | 0.100 |
Why?
|
| Basophils | 2 | 2010 | 7 | 0.090 |
Why?
|
| Protein Kinase C | 2 | 2014 | 47 | 0.090 |
Why?
|
| Electrons | 1 | 2011 | 16 | 0.090 |
Why?
|
| Monocytes | 1 | 2011 | 38 | 0.090 |
Why?
|
| Glucose | 1 | 2011 | 45 | 0.090 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2021 | 11 | 0.080 |
Why?
|
| Tetradecanoylphorbol Acetate | 5 | 2009 | 30 | 0.080 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2010 | 5 | 0.080 |
Why?
|
| Threonine | 1 | 2009 | 8 | 0.080 |
Why?
|
| Leukocytes | 1 | 2009 | 29 | 0.080 |
Why?
|
| Phagocytosis | 1 | 2009 | 20 | 0.080 |
Why?
|
| Arginine | 2 | 2022 | 17 | 0.080 |
Why?
|
| Superoxides | 3 | 2003 | 23 | 0.070 |
Why?
|
| Immunoglobulin E | 1 | 2008 | 9 | 0.070 |
Why?
|
| Hypersensitivity | 1 | 2008 | 38 | 0.070 |
Why?
|
| Static Electricity | 2 | 2021 | 43 | 0.070 |
Why?
|
| Binding, Competitive | 1 | 2007 | 20 | 0.060 |
Why?
|
| Phospholipases A | 1 | 2006 | 4 | 0.060 |
Why?
|
| Granulocytes | 1 | 2006 | 14 | 0.060 |
Why?
|
| Blood Bactericidal Activity | 1 | 2006 | 4 | 0.060 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 1 | 2006 | 4 | 0.060 |
Why?
|
| NADPH Oxidase 2 | 2 | 2002 | 5 | 0.060 |
Why?
|
| Microscopy, Confocal | 3 | 2010 | 80 | 0.060 |
Why?
|
| Hydrogen | 1 | 2004 | 6 | 0.060 |
Why?
|
| Intracellular Membranes | 1 | 2004 | 20 | 0.060 |
Why?
|
| Pulmonary Alveoli | 1 | 2004 | 20 | 0.060 |
Why?
|
| Kinetics | 3 | 2010 | 174 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 2 | 2013 | 59 | 0.050 |
Why?
|
| Models, Biological | 2 | 2021 | 302 | 0.050 |
Why?
|
| Mammals | 1 | 2022 | 19 | 0.050 |
Why?
|
| Cytosol | 1 | 2022 | 41 | 0.050 |
Why?
|
| Phosphorylation | 2 | 2014 | 130 | 0.050 |
Why?
|
| Mutation, Missense | 2 | 2013 | 26 | 0.040 |
Why?
|
| Proton-Motive Force | 1 | 2021 | 6 | 0.040 |
Why?
|
| Electromagnetic Fields | 1 | 2021 | 9 | 0.040 |
Why?
|
| Adult | 4 | 2009 | 6931 | 0.040 |
Why?
|
| Chlorides | 3 | 2006 | 25 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2020 | 9 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2014 | 243 | 0.040 |
Why?
|
| Heterografts | 1 | 2020 | 16 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 40 | 0.040 |
Why?
|
| Hydrogen Peroxide | 1 | 2020 | 39 | 0.040 |
Why?
|
| CRISPR-Cas Systems | 1 | 2020 | 12 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2020 | 76 | 0.040 |
Why?
|
| Cell Movement | 1 | 2020 | 77 | 0.040 |
Why?
|
| Amino Acids | 1 | 2019 | 18 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 111 | 0.040 |
Why?
|
| Cell Line | 2 | 2010 | 242 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2020 | 337 | 0.040 |
Why?
|
| Benzopyrans | 2 | 2009 | 7 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2010 | 276 | 0.040 |
Why?
|
| Isotonic Solutions | 2 | 2011 | 8 | 0.040 |
Why?
|
| Maleimides | 2 | 2009 | 6 | 0.040 |
Why?
|
| Carcinogens | 2 | 2009 | 8 | 0.040 |
Why?
|
| Indoles | 2 | 2009 | 32 | 0.040 |
Why?
|
| Enzyme Inhibitors | 2 | 2009 | 104 | 0.030 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 2 | 2008 | 12 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2011 | 462 | 0.030 |
Why?
|
| Fluorescent Dyes | 2 | 2009 | 34 | 0.030 |
Why?
|
| Temperature | 2 | 2010 | 56 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2017 | 24 | 0.030 |
Why?
|
| In Vitro Techniques | 2 | 2009 | 152 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2017 | 85 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2010 | 387 | 0.030 |
Why?
|
| Zinc Compounds | 2 | 2006 | 4 | 0.030 |
Why?
|
| Tritium | 1 | 2015 | 8 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2015 | 9 | 0.030 |
Why?
|
| Water | 1 | 2015 | 29 | 0.030 |
Why?
|
| Ions | 1 | 2015 | 45 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2014 | 37 | 0.030 |
Why?
|
| Phylogeny | 1 | 2013 | 40 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2011 | 9 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2011 | 6 | 0.020 |
Why?
|
| Sucrose | 1 | 2011 | 14 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2011 | 17 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2011 | 20 | 0.020 |
Why?
|
| Lysine | 1 | 2011 | 14 | 0.020 |
Why?
|
| Electric Conductivity | 1 | 2011 | 68 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2011 | 47 | 0.020 |
Why?
|
| Permeability | 1 | 2011 | 94 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2010 | 4 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2010 | 17 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2010 | 12 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2010 | 30 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 19 | 0.020 |
Why?
|
| Dimerization | 1 | 2010 | 20 | 0.020 |
Why?
|
| Oncogene Protein v-akt | 1 | 2010 | 8 | 0.020 |
Why?
|
| Syk Kinase | 1 | 2010 | 7 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2010 | 13 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2010 | 54 | 0.020 |
Why?
|
| Protein Kinase C-delta | 1 | 2009 | 10 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 20 | 0.020 |
Why?
|
| Transfection | 1 | 2010 | 115 | 0.020 |
Why?
|
| Mitochondria | 1 | 2010 | 55 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 43 | 0.020 |
Why?
|
| Naphthols | 1 | 2009 | 3 | 0.020 |
Why?
|
| Rhodamines | 1 | 2009 | 4 | 0.020 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 2009 | 6 | 0.020 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2008 | 4 | 0.020 |
Why?
|
| Histamine | 1 | 2008 | 7 | 0.020 |
Why?
|
| Proton Pump Inhibitors | 1 | 2008 | 11 | 0.020 |
Why?
|
| Okadaic Acid | 1 | 2006 | 5 | 0.020 |
Why?
|
| Arachidonic Acids | 1 | 2006 | 6 | 0.020 |
Why?
|
| Group IV Phospholipases A2 | 1 | 2006 | 4 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2006 | 39 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2006 | 90 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2006 | 71 | 0.010 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2005 | 6 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 313 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2006 | 363 | 0.010 |
Why?
|
| Acids | 1 | 2004 | 3 | 0.010 |
Why?
|
| Fluoresceins | 1 | 2004 | 5 | 0.010 |
Why?
|
| Potassium | 1 | 2004 | 59 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2004 | 70 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 314 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2003 | 52 | 0.010 |
Why?
|
| Algorithms | 1 | 2003 | 304 | 0.010 |
Why?
|
| Male | 1 | 2004 | 12460 | 0.000 |
Why?
|